MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Proton Radiation for Lymphoma Involving Mediastinum

Not Applicable

Terminated

Conditions: Lymphoma

Interventions: Radiation: Proton Radiation

First Posted Date: 2012-12-18

Last Posted Date: 2017-11-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT01751412

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption

Phase 4

Completed

Conditions: Postmenopausal Osteoporosis

Interventions: Drug: Teriparatide 40-mcg subcutaneous injection
Drug: Denosumab Injection
Drug: Alendronate Oral Tablet

First Posted Date: 2012-12-17

Last Posted Date: 2017-03-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 27

Registration Number: NCT01750086

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Tolerance Following Peanut Oral Immunotherapy

Phase 1

Completed

Conditions: Peanut Allergy

Interventions: Drug: Peanut Flour
Drug: Oat Flour

First Posted Date: 2012-12-17

Last Posted Date: 2021-07-28

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 41

Registration Number: NCT01750879

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy

Not Applicable

Terminated

Conditions: Prostate Cancer

Interventions: Device: Sonoelastography

First Posted Date: 2012-12-13

Last Posted Date: 2017-10-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4

Registration Number: NCT01748890

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Sonoelastography: Ultrasound Method to Measure Liver Fibrosis

Not Applicable

Completed

Conditions: Chronic Liver Disease
Hepatitis C Virus (HCV) Coinfection
Drug-Induced Liver Injury
Non-Alcoholic Fatty Liver Disease
Hepatitis B Virus (HBV)

Interventions: Device: Shear Wave Sonoelastography

First Posted Date: 2012-12-12

Last Posted Date: 2017-06-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 180

Registration Number: NCT01747772

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Symptom Tracking in Assisted Reproductive Technologies

Completed

Conditions: Depression Relapse in Women Undergoing Fertility Treatment

First Posted Date: 2012-12-11

Last Posted Date: 2018-01-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 49

Registration Number: NCT01746797

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation

Phase 2

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Afatinib

First Posted Date: 2012-12-10

Last Posted Date: 2020-07-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 92

Registration Number: NCT01746251

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 1 locations

Bevacizumab/Doxorubicin/Radiation for Sarcoma

Phase 1

Active, not recruiting

Conditions: Sarcoma

Interventions: Drug: Bevacizumab
Drug: Doxorubicin
Radiation: Radiation Therapy

First Posted Date: 2012-12-10

Last Posted Date: 2024-03-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 14

Registration Number: NCT01746238

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Other: Light exposure

First Posted Date: 2012-12-05

Last Posted Date: 2020-02-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 70

Registration Number: NCT01742182

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Detecting EGFR T790M Mutations From Circulating Tumor Cells

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Device: Circulating tumor cell chip

First Posted Date: 2012-11-28

Last Posted Date: 2016-09-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT01734915

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy